March-In Rights for Federally Funded Inventions: A Primer
Event Summary
Bayh-Dole’s “march-in” provision—which allows the government to mandate the relicensing of federally-funded innovations in limited circumstances—is often subject to misinterpretation. For nearly 20 years, critics have claimed that Bayh-Dole’s march-in right can be used as a price-setting mechanism—rather than a tool meant to ensure that private companies make good faith efforts to commercialize federally-funded inventions.
Please join ITIF and the Bayh-Dole Coalition for a video webinar that will clarify the provision’s intent and explain once and for all how Bayh-Dole’s march-in right can and cannot be used. Speakers will detail how misusing march-in rights as a price-setting mechanism would eliminate research, development, and investment incentives across the technology transfer, venture capital, and life sciences industries.
Speakers
![Joseph](https://cdn.sanity.io/images/03hnmfyj/production/3e8ce291ffc6b4fd56b9fe2594e11968271079ef-107x147.png?rect=0,2,107,145&w=64&h=87&or=0&q=100&fit=clip&auto=format)
![Lou](https://cdn.sanity.io/images/03hnmfyj/production/fb437d1fd836263d1f2261a2852eb9333c02a75d-107x147.jpg?rect=0,2,107,145&w=64&h=87&or=0&q=100&fit=clip&auto=format)
![Stephen](https://cdn.sanity.io/images/03hnmfyj/production/7405b41ee3ca3c4657865e3dd9b9964dbff2c82d-1680x2100.jpg?rect=224,58,1233,1676&w=64&h=87&or=0&q=100&fit=clip&auto=format)
![Kathy](https://cdn.sanity.io/images/03hnmfyj/production/e5f4b011883c24eed9361d7aa0b1db46336c2773-150x200.png?rect=2,0,147,200&w=64&h=87&or=0&q=100&fit=clip&auto=format)
![Wendy](https://cdn.sanity.io/images/03hnmfyj/production/9fedd2dac9440b36c2d590e2300ba586b7c3a9e8-107x147.png?rect=0,2,107,145&w=64&h=87&or=0&q=100&fit=clip&auto=format)
![Gillian](https://cdn.sanity.io/images/03hnmfyj/production/b6a29bc42097b732252ebf6656436382a91bb53a-107x147.jpg?rect=0,2,107,145&w=64&h=87&or=0&q=100&fit=clip&auto=format)